ConforMIS Inc (CFMS) Shares Sold by Laurion Capital Management LP

Laurion Capital Management LP decreased its stake in ConforMIS Inc (NASDAQ:CFMS) by 49.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 503,286 shares of the medical instruments supplier’s stock after selling 494,396 shares during the period. Laurion Capital Management LP’s holdings in ConforMIS were worth $629,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of CFMS. Deutsche Bank AG boosted its holdings in shares of ConforMIS by 43.5% in the 4th quarter. Deutsche Bank AG now owns 120,849 shares of the medical instruments supplier’s stock valued at $286,000 after buying an additional 36,634 shares in the last quarter. Schwab Charles Investment Management Inc. boosted its holdings in shares of ConforMIS by 93.2% in the 1st quarter. Schwab Charles Investment Management Inc. now owns 140,943 shares of the medical instruments supplier’s stock valued at $205,000 after buying an additional 68,000 shares in the last quarter. Northern Trust Corp boosted its holdings in shares of ConforMIS by 20.2% in the 1st quarter. Northern Trust Corp now owns 538,985 shares of the medical instruments supplier’s stock valued at $782,000 after buying an additional 90,447 shares in the last quarter. BlackRock Inc. boosted its holdings in shares of ConforMIS by 2.6% in the 1st quarter. BlackRock Inc. now owns 2,398,722 shares of the medical instruments supplier’s stock valued at $3,478,000 after buying an additional 61,539 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of ConforMIS by 79.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 91,356 shares of the medical instruments supplier’s stock valued at $132,000 after buying an additional 40,563 shares in the last quarter. Institutional investors and hedge funds own 40.13% of the company’s stock.

Several research analysts have recently issued reports on the stock. Zacks Investment Research cut shares of ConforMIS from a “buy” rating to a “hold” rating in a report on Monday, August 6th. Oppenheimer set a $4.00 target price on shares of ConforMIS and gave the company a “buy” rating in a report on Thursday, August 2nd. BTIG Research restated a “buy” rating and issued a $3.00 target price on shares of ConforMIS in a report on Thursday, August 2nd. SunTrust Banks restated a “buy” rating on shares of ConforMIS in a report on Monday, July 16th. Finally, ValuEngine upgraded shares of ConforMIS from a “sell” rating to a “hold” rating in a report on Friday, June 1st. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $3.25.

Shares of NASDAQ:CFMS opened at $1.11 on Monday. The firm has a market cap of $70.75 million, a P/E ratio of -0.90 and a beta of 1.12. The company has a quick ratio of 4.15, a current ratio of 4.77 and a debt-to-equity ratio of 0.60. ConforMIS Inc has a 1-year low of $0.88 and a 1-year high of $4.17.

ConforMIS (NASDAQ:CFMS) last issued its quarterly earnings results on Friday, August 3rd. The medical instruments supplier reported ($0.24) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.21) by ($0.03). The business had revenue of $19.10 million for the quarter, compared to analyst estimates of $19.52 million. ConforMIS had a negative return on equity of 94.69% and a negative net margin of 64.66%. research analysts expect that ConforMIS Inc will post -0.83 earnings per share for the current fiscal year.

ConforMIS Profile

ConforMIS, Inc, a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee.

Recommended Story: Understanding Stock Ratings

Want to see what other hedge funds are holding CFMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ConforMIS Inc (NASDAQ:CFMS).

Institutional Ownership by Quarter for ConforMIS (NASDAQ:CFMS)

Receive News & Ratings for ConforMIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConforMIS and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply